Nexa Resources is a low cost integrated zinc producer with a Q3 inflection, $100M profit, EBITDA surge and Aripuanã growth.
Coherus Oncology, Inc. is rated a Buy driven by a promising clinical pipeline and undervaluation. Learn more about CHRS stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback